798 – Efficacy and Safety of Open-Label Treatment with Tofacitinib 10 Mg Twice Daily in Patients with Ulcerativ Ecolitis with Clinical Response, But Not Remission, After 52 Weeks of Maintenance Therapy: Data from the Octave Studies
Gastroenterology（2019）
Key words
ulcerativ ecolitis,tofacitinib,treatment,clinical response,open-label
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined